American and German Trio Win 2026 Nobel Medicine Prize for Brain-Switch Discovery
The Nobel medicine prize 2026 has been awarded to American scientist Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel for their discoveries concerning light-gated ion channels and optogenetics, work that lets scientists switch individual brain cells on and off with light.
The Nobel Assembly at Sweden’s Karolinska Institutet announced the award in Stockholm on Monday. Deisseroth, 54, Hegemann, 71, and Nagel, 73, will share prize money of 12 million Swedish crowns, roughly $1.2 million.
What optogenetics does
Optogenetics works like a light-operated switch for nerve cells. By placing a light-sensitive protein into brain cells, researchers can activate or silence specific neurons with pulses of light, then observe what changes in behaviour, memory or feeling.
It “makes it possible to switch on, or off, the activity of individual nerve cells in a living brain,” said Thomas Perlmann, secretary-general of the Nobel Assembly. He added that the method is now used in laboratories around the world to reveal the brain’s mysteries.
The technique is already moving toward the clinic. In trials, researchers are restoring vision in people blinded by retinitis pigmentosa by inserting a light-sensitive protein in the retina. Scientists also hope it could sharpen cochlear implants, allowing more precise stimulation of the auditory nerve than today’s electrical devices.
Three decades of work behind the Nobel medicine prize 2026
The story began in the early 1990s, when Hegemann investigated how the single-celled alga Chlamydomonas reacts to light within half a millisecond. He proposed that a single protein both captured light and acted as an ion channel.
Nagel tested the idea by injecting genes from the alga into frog eggs, and the pair identified channelrhodopsin-2, an ion channel that opens when exposed to light. In 2003 they showed the protein could be placed in human and hamster cells to generate electrical impulses using light.
Deisseroth, working at Stanford University, took the decisive next step. In 2005 he demonstrated the technique in rat nerve cells, proving that light could control living neurons. The method was named optogenetics a year later.
Perlmann said he had spoken to all three laureates on Monday morning and found them surprised and delighted. “All three said the same thing, that they thought it was absolutely wonderful to receive the prize with the other two,” he said.
Nobel week begins
The medicine prize traditionally opens the annual Nobel announcements. Prizes in physics, chemistry, literature, peace and economics will follow over the coming days, with the awards presented in Stockholm on December 10, the anniversary of Alfred Nobel’s death.
Last year the medicine prize went to Americans Mary Brunkow and Fred Ramsdell and Japan’s Shimon Sakaguchi for research into how the immune system spares healthy cells, opening paths to new cancer treatments.
Who won the 2026 Nobel Prize in Medicine?
Karl Deisseroth of the United States and Peter Hegemann and Georg Nagel of Germany, for discoveries concerning light-gated ion channels and optogenetics.
What is optogenetics?
A technique that uses light to switch individual nerve cells on or off, letting scientists map which brain cells control specific functions, memories and behaviours.
How much is the Nobel Prize worth in 2026?
The three laureates will share 12 million Swedish crowns, about $1.2 million.
What comes next in Nobel week?
Physics, chemistry, literature, peace and economics prizes will be announced in the coming days.
